These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7036226)

  • 1. Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function.
    Leithner C; Sinzinger H; Schwarz M
    Prostaglandins; 1981 Nov; 22(5):783-8. PubMed ID: 7036226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabelled platelets and prostacyclin in diagnosis and treatment of transplant rejection.
    Leithner C; Sinzinger H; Schwarz M; Pohanka E
    Proc Eur Dial Transplant Assoc; 1983; 19():529-35. PubMed ID: 6410383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [111-Indium-labeled thrombocytes in the diagnosis of acute kidney transplant rejections and in monitoring the therapy of rejection reactions with prostacyclin].
    Leithner C; Sinzinger H; Pohanka E; Schwarz M; Syré G
    Wien Klin Wochenschr; 1984 Feb; 96(3):112-7. PubMed ID: 6372258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some remarks on the complex behaviour of platelet function during and after prostacyclin treatment.
    Sinzinger H; Silberbauer K; Leithner C; Schwarz M
    Vasa; 1981; 10(4):348-9. PubMed ID: 7032112
    [No Abstract]   [Full Text] [Related]  

  • 5. Short term suppression of hyperacute renal allograft rejection in presensitised dogs with prostacyclin.
    Mundy AR; Bewick M; Moncada S; Vane JR
    Prostaglandins; 1980 Apr; 19(4):595-603. PubMed ID: 6992233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced prostacyclin synthesis in acute human kidney transplant rejection.
    Leithner C; Sinzinger H; Silberbauer K; Wolf A; Stummvoll HK; Pinggera W
    Proc Eur Dial Transplant Assoc; 1980; 17():424-8. PubMed ID: 7017684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostacyclin infusion on platelet activation and postoperative blood loss in coronary bypass.
    Aren C; Feddersen K; Rådegran K
    Ann Thorac Surg; 1983 Jul; 36(1):49-54. PubMed ID: 6222712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of the prostacyclin story for clinical use].
    Sinzinger H; Silberbauer K
    Vasa; 1981; 10(1):70-3. PubMed ID: 7015718
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a stable prostacyclin analogue on canine renal allograft rejection.
    Tobimatsu M; Ueda Y; Toyoda K; Saito S; Konomi K
    Ann Surg; 1987 Feb; 205(2):199-202. PubMed ID: 3545109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative study of indium-111-oxine platelet kinetics in acute and chronic renal transplant rejection.
    Heyns AD; Lötter MG; Pieters H; Pauw FH; Badenhorst PN; Wessels P; Minnaar PC
    Clin Nephrol; 1982 Oct; 18(4):174-82. PubMed ID: 6814802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?
    Sinzinger H; Silberbauer K; Horsch AK; Gall A
    Prostaglandins; 1981 Jan; 21(1):49-51. PubMed ID: 7010457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet activity after termination of prostacyclin infusion into man.
    Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
    Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prostacyclin on cerebral vasospasm. An experimental study.
    Quintana L; Konda R; Ishibashi Y; Yoshimoto T; Suzuki J
    Acta Neurochir (Wien); 1982; 62(3-4):187-93. PubMed ID: 7048862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Belch JJ; McKay A; McArdle B; Leiberman P; Pollock JG; Lowe GD; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):315-7. PubMed ID: 6130330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical potential of prostacyclin.
    Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():449-56. PubMed ID: 6221561
    [No Abstract]   [Full Text] [Related]  

  • 16. New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation.
    Teraoka S; Takahashi K; Toma H; Yagisawa T; Yamaguchi Y; Sanaka T; Fuchinoue S; Honda H; Kawai T; Tanabe K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2115-9. PubMed ID: 3547915
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor.
    Kemp E; Steinbrüchel D; Starklint H; Larsen S; Henriksen I; Dieperink H
    Transplant Proc; 1987 Dec; 19(6):4471-4. PubMed ID: 2827356
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-platelet action of intravenous infusion of prostacyclin in man.
    Gryglewski RJ; Szczeklik A; Nizankowski R
    Thromb Res; 1978 Aug; 13(2):153-63. PubMed ID: 358486
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental assessment of prostacyclin in the harvesting of kidneys for transplantation.
    Mundy AR; Bewick M; Moncada S; Vane JR
    Transplantation; 1980 Oct; 30(4):251-5. PubMed ID: 7003843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor and prostacyclin in kidney transplant rejection.
    Sinzinger H; Zidek T; Foegh ML
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):102-7. PubMed ID: 3303560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.